These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 12939421

  • 1. Donepezil in vascular dementia: a randomized, placebo-controlled study.
    Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD, Donepezil 308 Study Group.
    Neurology; 2003 Aug 26; 61(4):479-86. PubMed ID: 12939421
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R, Donepezil 307 Vascular Dementia Study Group.
    Stroke; 2003 Oct 26; 34(10):2323-30. PubMed ID: 12970516
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Donepezil for vascular cognitive impairment.
    Malouf R, Birks J.
    Cochrane Database Syst Rev; 2004 Oct 26; (1):CD004395. PubMed ID: 14974068
    [Abstract] [Full Text] [Related]

  • 5. Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia.
    Pratt RD.
    J Neurol Sci; 2002 Nov 15; 203-204():57-65. PubMed ID: 12417358
    [Abstract] [Full Text] [Related]

  • 6. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials.
    Román GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ.
    Dement Geriatr Cogn Disord; 2005 Nov 15; 20(6):338-44. PubMed ID: 16192723
    [Abstract] [Full Text] [Related]

  • 7. Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.
    Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P, Donepezil MSAD Study Investigators' Group.
    Curr Med Res Opin; 2002 Nov 15; 18(6):347-54. PubMed ID: 12442882
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Donepezil: in vascular dementia.
    Goldsmith DR, Scott LJ.
    Drugs Aging; 2003 Nov 15; 20(15):1127-36. PubMed ID: 14651435
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP, Bayer AJ, Steinhagen-Thiessen E.
    J Neurol Sci; 2005 Mar 15; 229-230():141-6. PubMed ID: 15760632
    [Abstract] [Full Text] [Related]

  • 13. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial.
    Mori E, Ikeda M, Kosaka K, Donepezil-DLB Study Investigators.
    Ann Neurol; 2012 Jul 15; 72(1):41-52. PubMed ID: 22829268
    [Abstract] [Full Text] [Related]

  • 14. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group.
    Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, Nishimura T.
    Dement Geriatr Cogn Disord; 2000 Jul 15; 11(6):299-313. PubMed ID: 11044775
    [Abstract] [Full Text] [Related]

  • 15. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.
    Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E, Donepezil MSAD Study Investigators Group.
    Neurology; 2001 Aug 28; 57(4):613-20. PubMed ID: 11524468
    [Abstract] [Full Text] [Related]

  • 16. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Memantine Study Group.
    JAMA; 2004 Jan 21; 291(3):317-24. PubMed ID: 14734594
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM, Donepezil MSAD Study Investigators Group.
    Int J Geriatr Psychiatry; 2005 Jun 21; 20(6):559-69. PubMed ID: 15920715
    [Abstract] [Full Text] [Related]

  • 18. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R, AWARE Study Group.
    CNS Drugs; 2006 Jun 21; 20(4):311-25. PubMed ID: 16599649
    [Abstract] [Full Text] [Related]

  • 19. The effects of donepezil in Alzheimer's disease - results from a multinational trial.
    Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT.
    Dement Geriatr Cogn Disord; 1999 Jun 21; 10(3):237-44. PubMed ID: 10325453
    [Abstract] [Full Text] [Related]

  • 20. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
    Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, Moline ML.
    Mov Disord; 2012 Sep 01; 27(10):1230-8. PubMed ID: 22915447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.